ARACELI SIERRA: Open Payments
NPI 1861483000 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 42 payments from 12 companies in 2025. Trend: 2023 $1,053 · 2024 $1,270 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $285 |
| Novo Nordisk Inc | 10 | $230 |
| Lilly USA, LLC | 3 | $56 |
| Almatica Pharma LLC | 2 | $51 |
| ABBVIE INC. | 2 | $49 |
| Abbott Laboratories | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Amgen Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Rybelsus, FARXIGA, AIRSUPRA, Ozempic, MOUNJARO, LOREEV XR, FREESTYLE LIBRE 3, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
